Splicing modulation therapy in the treatment of genetic diseases

被引：32

作者：

Arechavala-Gomeza, Virginia ^{[1
]}

Khoo, Bernard ^{[2
]}

Aartsma-Rus, Annemieke ^{[3
]}

机构：

[1] BioCruces Hlth Res Inst, Neuromuscular Disorders Grp, Baracaldo, Bizkaia, Spain

[2] UCL, Div Med, Endocrinol, London, England

[3] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands

来源：

APPLICATION OF CLINICAL GENETICS | 2014年 / 7卷

关键词：

splicing; therapy; antisense oligonucleotides; cryptic splicing; alternative splicing;

D O I：

10.2147/TACG.S71506

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

Antisense-mediated splicing modulation is a tool that can be exploited in several ways to provide a potential therapy for rare genetic diseases. This approach is currently being tested in clinical trials for Duchenne muscular dystrophy and spinal muscular atrophy. The present review outlines the versatility of the approach to correct cryptic splicing, modulate alternative splicing, restore the open reading frame, and induce protein knockdown, providing examples of each. Finally, we outline a possible path forward toward the clinical application of this approach for a wide variety of inherited rare diseases.

引用

页码：245 / 252

页数：8

共 65 条

[51] Pharmacology of a Central Nervous System Delivered 2′-O-Methoxyethyl-Modified Survival of Motor Neuron Splicing Oligonucleotide in Mice and Nonhuman Primates
Rigo, Frank
Chun, Seung J.
Norris, Daniel A.
Hung, Gene
Lee, Sam
Matson, John
Fey, Robert A.
Gaus, Hans
Hua, Yimin
Grundy, John S.
Krainer, Adrian R.
Henry, Scott P.
Bennett, C. Frank
[J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2014, 350 (01) : 46 - 55
[52] Pick one, but be quick: 5′ splice sites and the problems of too many choices
Roca, Xavier
Krainer, Adrian R.
Eperon, Ian C.
[J]. GENES & DEVELOPMENT, 2013, 27 (02) : 129 - 144
[53] Saleh AF, 2012, METHODS MOL BIOL, V867, P365, DOI 10.1007/978-1-61779-767-5_23
[54] Reversal of the cellular phenotype in the premature aging disease Hutchinson-Gilford progeria syndrome
Scaffidi, P
Misteli, T
[J]. NATURE MEDICINE, 2005, 11 (04) : 440 - 445
[55] Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs
Soutschek, J
Akinc, A
Bramlage, B
Charisse, K
Constien, R
Donoghue, M
Elbashir, S
Geick, A
Hadwiger, P
Harborth, J
John, M
Kesavan, V
Lavine, G
Pandey, RK
Racie, T
Rajeev, KG
Röhl, I
Toudjarska, I
Wang, G
Wuschko, S
Bumcrot, D
Koteliansky, V
Limmer, S
Manoharan, M
Vornlocher, HP
[J]. NATURE, 2004, 432 (7014) : 173 - 178
[56] Human tra2-beta1 autoregulates its protein concentration by influencing alternative splicing of its pre-mRNA
Stoilov, P
Daoud, R
Nayler, O
Stamm, S
[J]. HUMAN MOLECULAR GENETICS, 2004, 13 (05) : 509 - 524
[57] RNA repair restores hemoglobin expression in IVS2-654 thalassemic mice
Svasti, Saovaros
Suwanmanee, Thipparat
Fucharoen, Suthat
Moulton, Hong M.
Nelson, Michelle H.
Maeda, Nobuyo
Smithies, Oliver
Kole, Ryszard
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (04) : 1205 - 1210
[58] Quantification of dystrophin immunofluorescence in dystrophinopathy muscle specimens
Taylor, L. E.
Kaminoh, Y. J.
Rodesch, C. K.
Flanigan, K. M.
[J]. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2012, 38 (06) : 591 - 601
[59] Local dystrophin restoration with antisense oligonucleotide PRO051
van Deutekom, Judith C.
Janson, Anneke A.
Ginjaar, Ieke B.
Frankhuizen, Wendy S.
Aartsma-Rus, Annemieke
Bremmer-Bout, Mattie
den Dunnen, Johan T.
Koop, Klaas
van der Kooi, Anneke J.
Goemans, Nathalie M.
de Kimpe, Sjef J.
Ekhart, Peter F.
Venneker, Edna H.
Platenburg, Gerard J.
Verschuuren, Jan J.
van Ommen, Gert-Jan B.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (26) : 2677 - 2686
[60] van Roon-Mom WMC, 2012, METHODS MOL BIOL, V867, P79, DOI 10.1007/978-1-61779-767-5_6

← 1 2 3 4 5 6 7 →